Skip to main content
Log in

The EQ-5D should be considered for use in future cost-effectiveness studies

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Barton GR, Hodgekins J, Mugford M, Jones PB, Croudace T, Fowler D.Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D. British Journal of Psychiatry 195: 170-177, No. 2, Aug 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The EQ-5D should be considered for use in future cost-effectiveness studies. Pharmacoecon. Outcomes News 587, 4 (2009). https://doi.org/10.2165/00151234-200905870-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905870-00010

Keywords

Navigation